CStone Pharmaceuticals (HKSE:02616) Accounts Payable : HK$0.0 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Accounts Payable?

CStone Pharmaceuticals's Accounts Payable for the quarter that ended in Jun. 2023 was HK$0.0 Mil.

CStone Pharmaceuticals's quarterly Accounts Payable increased from Jun. 2022 (HK$86.7 Mil) to Dec. 2022 (HK$324.3 Mil) but then declined from Dec. 2022 (HK$324.3 Mil) to Jun. 2023 (HK$0.0 Mil).

CStone Pharmaceuticals's annual Accounts Payable declined from Dec. 2021 (HK$507.3 Mil) to Dec. 2022 (HK$324.3 Mil) and declined from Dec. 2022 (HK$324.3 Mil) to Dec. 2023 (HK$269.5 Mil).

CStone Pharmaceuticals Accounts Payable Historical Data

The historical data trend for CStone Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Accounts Payable Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

41.51

33.23

507.29

324.31

269.48

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial									507.29	86.73	324.31	-	269.48

CStone Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

CStone Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (HKSE:02616) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

CSPHF:USA PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (HKSE:02616) Headlines

No Headlines